- Home
- CHRW vs PODD Comparison
CHRW vs PODD Comparison
Compare CHRW & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHRW | PODD |
|---|---|---|
| Founded | 1905 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.6B | 22.1B |
| IPO Year | 1997 | 2007 |
Fundamental Metrics
Financial Performance| Metric | CHRW | PODD |
|---|---|---|
| Price | $153.36 | $296.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 22 | 19 |
| Target Price | $138.24 | ★ $359.00 |
| AVG Volume (30 Days) | ★ 1.4M | 751.9K |
| Earning Date | 01-28-2026 | 11-06-2025 |
| Dividend Yield | ★ 1.64% | N/A |
| EPS Growth | ★ 70.68 | N/A |
| EPS | ★ 4.94 | 3.45 |
| Revenue | ★ $16,504,785,000.00 | $2,521,800,000.00 |
| Revenue This Year | N/A | $32.55 |
| Revenue Next Year | $3.08 | $20.39 |
| P/E Ratio | ★ $31.07 | $85.83 |
| Revenue Growth | N/A | ★ 27.11 |
| 52 Week Low | $84.68 | $230.05 |
| 52 Week High | $162.79 | $354.88 |
Technical Indicators
Market Signals| Indicator | CHRW | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 53.40 | 37.28 |
| Support Level | $158.37 | $303.20 |
| Resistance Level | $162.79 | $317.34 |
| Average True Range (ATR) | 3.26 | 13.25 |
| MACD | -0.78 | -3.48 |
| Stochastic Oscillator | 33.96 | 0.63 |
Price Performance
Historical ComparisonAbout CHRW C.H. Robinson Worldwide Inc.
C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (about 60% of net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm operates a large air and ocean forwarding division (30%), which has grown organically and via tuck-in acquisitions over the years. The remainder of revenue consists of transportation management services and a legacy produce-sourcing operation.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.